Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years-Reference-Cited by-同舟云学术

Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years

Published:2015-07-30 Issue:4 Volume:84 Page:587-597
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Jung Kyong Yeun¹,Kim Seok-Mo²,Yoo Won Sang³⁴,Kim Bup-Woo²,Lee Yong Sang²,Kim Kyung Won³,Lee Kyu Eun⁵,Jeong Jong Ju²,Nam Kee-Hyun²,Lee Se Hoon³⁶,Hah Jeong Hun⁷,Chung Woong Youn²,Yi Ka Hee³⁸,Park Do Joon³⁶,Youn Yeo-Kyu⁵,Sung Myung-Whun⁷,Cho Bo Youn³⁹,Park Cheong Soo²,Park Young Joo³⁶,Chang Hang-Seok²

Affiliation:

1. Department of Internal Medicine; Seoul National University Bundang Hospital; Seongnam Korea

2. Department of Surgery; Yonsei University College of Medicine; Seoul Korea

3. Department of Internal Medicine; Seoul National University College of Medicine; Seoul Korea

4. Department of Internal Medicine; Dankook University College of Medicine; Cheonan Korea

5. Department of Surgery; Seoul National University College of Medicine; Seoul Korea

6. Department of Internal Medicine; Seoul National University Hospital; Seoul Korea

7. Department of Otorhinolaryngology-Head and Neck Surgery; Seoul National University College of Medicine; Seoul Korea

8. Department of Internal Medicine; Seoul National University Boramae Medical Center; Seoul Korea

9. Department of Internal Medicine; Chung-Ang University College of Medicine; Seoul Korea

Funder

Korean Foundation for Cancer Research

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Reference30 articles.

1. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems;Kebebew;Cancer,2000

2. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients;Pelizzo;European Journal of Surgical Oncology,2007

3. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'etude des tumeurs a calcitonine;Modigliani;Clinical Endocrinology,1998

4. 2012 European thyroid association guidelines for metastatic medullary thyroid cancer;Schlumberger;European Thyroid Journal,2012

5. Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer;Miccoli;Endocrine-Related Cancer,2007

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival in medullary thyroid carcinoma patients who fail to achieve a biochemical cure: implications of postoperative 1-month calcitonin levels and targeted therapy;World Journal of Surgical Oncology;2024-09-12

2. Fumarate-1 Mediates the Regulation of Mitochondrial Homeostasis by PGC-1α to Promote Cell Pyroptosis and Inhibit the Progression of Thyroid Cancer;Recent Patents on Anti-Cancer Drug Discovery;2024-07-11

3. Studies on surgical methods for sporadic micromedullary thyroid carcinoma;Oncology and Translational Medicine;2024-06-04

4. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma;World Journal of Surgical Oncology;2024-05-06

5. Changes of biochemical factors and the effect on recurrence of medullary thyroid carcinoma after surgery;Heliyon;2024-04